Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Frontiers in Oncology|July 23, 2026
Salvage resection for FGFR2 fusion-positive intrahepatic cholangiocarcinoma after pemigatinib therapy: a case report and literature reviewYuhang Kang, Fei Xie, Zhenru Wu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 20, 2017
Postoperative Prognostic Nutritional Index Predicts Survival of Patients with Hepatocellular Carcinoma within Milan Criteria and HypersplenismXiaoyun Zhang, Chuan Li, Tianfu Wen, et al.
ANZ Journal of Surgery|April 25, 2018
Model predicting the microvascular invasion and satellite lesions of hepatocellular carcinoma after hepatectomyJunyi Shen, Tianfu Wen, Weixia Chen, et al.
Digestive Diseases (Basel, Switzerland)|April 20, 2018
The Prognostic Prediction Role of Preoperative Serum Albumin Level in Patients with Intahepatic Cholangiocarcinoma Following HepatectomyJunyi Shen, Tianfu Wen, Chuan Li, et al.
Frontiers in Oncology|June 28, 2021
LLGL2 Increases Ca2+ Influx and Exerts Oncogenic Activities via PI3K/AKT Signaling Pathway in Hepatocellular CarcinomaShusheng Leng, Fei Xie, Junyi Liu, et al.
Trials|December 2, 2023
The effect of switch therapy to tenofovir versus entecavir maintenance on recurrence of hepatocellular carcinoma after surgery (SWITE): study protocol for a randomized controlled trialWei Peng, Mengshi Yi, Xin Qi, et al.
BMC Surgery|September 8, 2021
Postoperative controlling nutritional status score is an independent risk factor of survival for patients with small hepatocellular carcinoma: a retrospective studyWei Peng, Minghong Yao, Kang Zou, et al.
Hepato-Gastroenterology|July 16, 2015
Predictive Value of Alpha-fetoprotein in the Survival of Living Donor Liver Transplantation Recipients for Hepatocellular CarcinomaLi Jiang, Anque Liao, Lunan Yan, et al.
International Journal of Surgery (London, England)|September 12, 2017
Treatment for intrahepatic recurrence after curative resection of hepatocellular carcinoma: Salvage liver transplantation or re-resection/radiofrequency ablation? A Retrospective Cohort StudyXiaoyun Zhang, Chuan Li, Tianfu Wen, et al.
Frontiers in Oncology|May 4, 2023
TIDE: adjuvant tislelizumab plus donafenib combined with transarterial chemoembolization for high-risk hepatocellular carcinoma after surgery: protocol for a prospective, single-arm, phase II trialWeili Qi, Wei Peng, Xin Qi, et al.
Pageof 17